Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics
FOLD Price/Volume Stats
| Current price | $9.51 | 52-week high | $14.03 |
| Prev. close | $9.41 | 52-week low | $8.78 |
| Day low | $9.40 | Volume | 1,774,500 |
| Day high | $9.63 | Avg. volume | 2,434,942 |
| 50-day MA | $9.79 | Dividend yield | N/A |
| 200-day MA | $10.43 | Market Cap | 2.84B |
FOLD Stock Price Chart Interactive Chart >
Amicus Therapeutics, Inc. (FOLD) Company Bio
Amicus Therapeutics is developing treatments for a broad range of human genetic diseases, with a focus on delivering new benefits to individuals with lysosomal storage disorders. The company was founded in 2002 and is based in Cranbury, New Jersey.
FOLD Price Returns
| 1-mo | -3.35% |
| 3-mo | -19.13% |
| 6-mo | -6.58% |
| 1-year | -23.68% |
| 3-year | 5.78% |
| 5-year | 6.38% |
| YTD | 0.96% |
| 2024 | -33.62% |
| 2023 | 16.22% |
| 2022 | 5.71% |
| 2021 | -49.98% |
| 2020 | 137.06% |
Continue Researching FOLD
Here are a few links from around the web to help you further your research on Amicus Therapeutics Inc's stock as an investment opportunity:Amicus Therapeutics Inc (FOLD) Stock Price | Nasdaq
Amicus Therapeutics Inc (FOLD) Stock Quote, History and News - Yahoo Finance
Amicus Therapeutics Inc (FOLD) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...